ABG-WTT Global Life Science Capital Partners GP Ltd
CIK 1832108 · View on SEC EDGAR ↗
- Portfolio value
- $8.6M
- Positions
- 2
- As of
- June 30, 2026
Portfolio value QoQ: -30.4% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 2
- Effective number of positions
- 1.9
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $0 · sells $3,238,270
Median holding: 4.5 quarters Tracked Q4 2024–Q2 2026 · 50.0% still held
- New positions
- 0
- Increased
- 0
- Decreased
- 1
- Closed
- 2
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: -18.6% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Full portfolio 2 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| CBLL CeriBell, Inc. - Common Stock | $5,355,130 | 62.61% | 275,328 | $-2,743,431 | Down ×1 | ||
| RPID Rapid Micro Biosystems, Inc. - Class A Common Stock | $3,197,552 | 37.39% | 1,848,296 | $-998,080 | |||
| No matches | |||||||
Top movers (QoQ)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.